5-Amino-1MQ NNMT Inhibitor vs AOD-9604 — Experimental Insights on Fat Metabolism

5-amino-1MQ, a small molecule NNMT inhibitor, and AOD-9604, a peptide fragment derived from human growth hormone, have both garnered significant attention in laboratory research focused on fat metabolism and metabolic regulation. This article provides a comprehensive, research-focused comparison of these two compounds, examining their mechanisms, published evidence, safety profiles, and regulatory considerations for laboratory use.

How does 5-Amino-1MQ NNMT work at the molecular level?

5-amino-1MQ (5-amino-1-methylquinolinium) is a synthetic small molecule that functions as an inhibitor of nicotinamide N-methyltransferase (NNMT). NNMT is an enzyme implicated in cellular methylation processes and metabolic regulation. By inhibiting NNMT, 5-amino-1MQ has been shown in preclinical studies to influence fat metabolism, energy expenditure, and adipocyte biology.

• Compound Class: NNMT inhibitor
• Molecular Weight: ~173.2 g/mol
• Primary Research Focus: Fat metabolism, adipocyte function, metabolic diseases

How does 5-Amino-1MQ NNMT work at the molecular level?

AOD-9604 is a synthetic peptide consisting of amino acids 176-191 of human growth hormone. It was originally developed to explore the lipolytic (fat-reducing) fragments of growth hormone without the anabolic or diabetogenic effects. In research protocols, AOD-9604 has been investigated for its potential to modulate adipose tissue metabolism and stimulate lipolysis in experimental models.

• Compound Class: Peptide (GH fragment)
• Amino Acid Sequence: Tyr-Leu-Asn-Gln-Tyr-Ser-Thr-Ser-Ile-Cys-Gly-Glu
• Primary Research Focus: Fat metabolism, obesity models, metabolic pathways

How does 5-Amino-1MQ NNMT compare to alternatives in research?

What does the research say about 5-Amino-1MQ NNMT?

5-Amino-1MQ

Multiple preclinical studies have demonstrated that 5-amino-1MQ administration in laboratory models results in decreased adiposity, improved energy expenditure, and alterations in NAD+ metabolism. Research suggests that NNMT inhibition may play a role in modulating the differentiation and function of adipocytes, as well as impacting pathways involved in cellular aging and metabolic regulation. These findings are largely based on animal and in vitro studies; clinical data remains limited.

AOD-9604

Published research has shown that AOD-9604 can stimulate lipolysis and inhibit lipogenesis in preclinical models. Unlike full-length growth hormone, AOD-9604 does not appear to increase IGF-1 levels or induce anabolic effects, making it a subject of interest for studies on selective fat metabolism pathways. Its effects have been observed primarily in rodent and cell culture models. Human data are limited and mixed, with most research focusing on safety and pharmacokinetics rather than definitive efficacy.

What safety considerations apply to 5-Amino-1MQ NNMT research?

5-Amino-1MQ

• Preclinical models have not reported significant toxicity at research concentrations.
• Potential off-target effects due to NNMT inhibition are possible, as the enzyme is involved in methylation processes throughout the body.
• Long-term safety and comprehensive toxicology data are lacking; further research is needed to clarify the risk profile.

AOD-9604

• Published studies indicate a favorable safety profile in animal models, with no significant impact on glucose metabolism or IGF-1 levels.
• Some reports in early human studies noted mild adverse events such as headache or local irritation in experimental protocols.
• No evidence of carcinogenicity or severe toxicity in published preclinical research; however, long-term data remain limited.

What does the research say about 5-Amino-1MQ NNMT?

Both 5-amino-1MQ and AOD-9604 are offered exclusively for research use in the United States. Neither compound is FDA-approved as a drug, supplement, or for human consumption. It is important to note that in 2024, AOD-9604 was excluded from the FDA’s bulk substance compounding list, which restricts pharmacy compounding but does not affect research supply. 5-amino-1MQ is not an FDA-approved medication and is not scheduled as a controlled substance; it is legal to purchase for laboratory research.

How does 5-Amino-1MQ NNMT compare to alternatives in research?

What are the most common questions about 5-Amino-1MQ NNMT?

What is 5-amino-1MQ and how does it work in research?

5-amino-1MQ is a small molecule NNMT inhibitor studied for its effects on fat metabolism and energy expenditure in laboratory models. It works by inhibiting the enzyme NNMT, which plays a role in methylation and NAD+ metabolism, potentially impacting adipocyte function and metabolic regulation according to preclinical research.

How does AOD-9604 compare to 5-amino-1MQ in research settings?

AOD-9604 is a peptide fragment derived from human growth hormone, primarily studied for its ability to stimulate lipolysis without anabolic effects. While both compounds are researched for fat metabolism, they act via different mechanisms—AOD-9604 on fat breakdown and 5-amino-1MQ on NNMT inhibition and metabolic pathways.

Are there known side effects or safety concerns for these compounds?

In preclinical studies, 5-amino-1MQ has not shown significant toxicity at research concentrations, though long-term safety data are lacking. AOD-9604 has a favorable safety profile in animal models, with limited mild adverse effects reported in experimental human protocols. Comprehensive safety profiles require further study.

Is it legal to purchase 5-amino-1MQ and AOD-9604 for research?

Both 5-amino-1MQ and AOD-9604 are legal to purchase for laboratory research in the US. They are not FDA-approved drugs or supplements, and are not intended for human consumption. AOD-9604 was excluded from pharmacy compounding in 2024 but remains available for research use.

Which compound is better for fat metabolism studies?

The choice depends on research objectives. 5-amino-1MQ targets NNMT and is studied for broader metabolic effects, while AOD-9604 directly influences fat breakdown. Both have demonstrated activity in preclinical models, but their mechanisms and applications differ. Comparative effectiveness depends on the experimental context.

What are the key takeaways from 5-Amino-1MQ NNMT research?

5-amino-1MQ and AOD-9604 represent two distinct research tools for investigating fat metabolism and metabolic pathways. 5-amino-1MQ acts as an NNMT inhibitor and is widely studied for its potential impact on cellular energy balance, while AOD-9604 is a peptide fragment that promotes lipolysis through mechanisms independent of growth hormone’s anabolic effects. Both compounds are strictly for research use, with unique advantages and limitations based on their molecular class and mechanism. Ongoing research will continue to clarify their roles in metabolic investigations.

What does the research say about 5-Amino-1MQ NNMT?

Order 5-amino-1MQ 50mg from Precision Peptide MD — ≥98% purity, COA with every order. For laboratory research use only. Not for human consumption or therapeutic applications.